AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (10.9 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Open Access

Parboiled rice supplementation alleviates high-fat diet-induced hyperlipidemia by regulating genes and gut microbiota in mice

Xiuxiu WuaTianyi GuoaBiao LibShuai HanaZuomin HuaYi LuocDandan QinaYaping ZhouaFeijun Luoa( )Qinlu Lina( )
National Research Center of Rice Deep Process and Byproducts, Hunan Provincial Key Laboratory of Grain-oil Deep Process and Quality Control, Hunan Provincial Key Laboratory of Forestry Edible Resources Safety and Processing, Central South University of Forestry and Technology, Changsha 410004, China
College of Life Science and Technology, Central South University of Forestry and Technology, Changsha 410004, China
Department of Clinical Medicine, Medical College of Xiangya, Central South University, Changsha 410008, China

Peer review under responsibility of Tsinghua University Press.

Show Author Information

Highlights

• Parboiled rice possessed strong lipid-lowering effect

• Parboiled rice regulated lipid and inflammation-related genes to balance blood lipids

• Ptpcr may play an important role in the lipid-lowering effect of parboiled rice

• Parboiled rice alleviated hyperlipidemia by modulating gut microbiota

• PPAR pathway may act as a bridge between liver genes and gut microbiota

Graphical Abstract

Abstract

Dietary parboiled rice (PR) has a low risk of disease, but little is known about the contribution of PR to the prevention of hyperlipidemia. The potential role and underlying mechanisms of PR in hyperlipidemia were evaluated in this study. Male C57BL/6J mice were fed with a normal diet, high-fat diet (HFD) containing refined rice (HFDRR) or PR (HFDPR). It was found that PR intervention improved lipid accumulation in mice. Transcriptomic data analysis revealed that 27 genes were up-regulated (mostly involved in lipid breakdown) and 86 genes were down-regulated (mostly involved in inflammatory responses) in the HFDPR group compared to the HFDRR group. And 15 differentially expressed genes (DEGs) were validated by quantitative real-time PCR (RT-qPCR), while protein interaction network showed that protein tyrosine phosphatase receptor type C (PTPRC) has a central role. The gut microbiota of mice was also altered after different dietary treatments, with higher ratio of Firmicutes and Bacteroidetes, increased abundances of Ruminococcaceae, Lachnospiraceae, Christensenellaceae, Porphyromonadaceae, Rikenellaceae and Prevotellaceae, and decreased abundances of Lactobacillaceae, Peptostreptococcaceae, Erysipelotrichaceae and Actinobacteria in the HFDRR group. In addition, it was observed that PPAR signaling pathway may act as a bridge between DEGs and differential gut microbiota. These results suggested that PR can prevent hyperlipidemia by modulating liver genes and gut microbiota.

Electronic Supplementary Material

Download File(s)
fshw-13-3-1422_ESM.docx (24 KB)

References

[1]

R.H. Nelson, Hyperlipidemia as a risk factor for cardiovascular disease, Prim. Care Clin. Office Pract. 40 (2013) 195-211. https://doi.org/10.1016/j.pop.2012.11.003.

[2]

J.R. Blanchfiele, Genetically modified food crops and their contribution to human nutrition and food quality, J. Food Sci. 69 (2004) 28-30. https://doi.org/10.1111/j.1365-2621.2004.tb17846.x.

[3]

P. Oli, R. Ward, B. Adhikari, et al., Parboiled rice: understanding from a materials science approach, J. Food Eng. 124 (2014) 173-183. https://doi.org/10.1016/j.jfoodeng.2013.09.010.

[4]

J. Tian, Y. Cai, W. Qin, et al., Parboiling reduced the crystallinity and in vitro digestibility of non-waxy short grain rice, Food Chem. 257 (2018) 23-28. https://doi.org/10.1016/j.foodchem.2018.03.005.

[5]

Y. Saroj, I.B. Hameeda, A. Jayadeep, Neuroprotective and hepatoprotective effect of whole red rice forms against oxidative stress in streptozotocin induced diabetic rats, Indian J. Exp. Biol. 58 (2020) 151-160.

[6]

S.N. Rao, G.R. Chandak, Cardiac beriberi: often a missed diagnosis, J. Trop. Pediatr. 56 (2010) 284-285. https://doi.org/10.1093/tropej/fmp108.

[7]

K. Wunjuntuk, A. Kettawan, S. Charoenkiatkul, et al., Parboiled germinated brown rice protects against CCl4-induced oxidative stress and liver injury in rats, J. Med. Food 19 (2016) 15-23. https://doi.org/10.1089/jmf.2015.3460.

[8]

S. Tuntipopipat, C. Muangnoi, P. Thiyajai, et al., A bioaccessible fraction of parboiled germinated brown rice exhibits a higher anti-inflammatory activity than that of brown rice, Food Funct. 6 (2015) 1480-1488. https://doi.org/10.1039/c4fo01194e.

[9]

L.W. Lu, B. Venn, J. Lu, et al., Effect of cold storage and reheating of parboiled rice on postprandial glycaemic response, satiety, palatability and chewed particle size distribution, Nutrients 9 (2017) 475-487. https://doi.org/10.3390/nu9050475.

[10]

H.B.N. Itagi, S.R. Pradeep, V. Singh, et al., Beneficial influence of phosphorylated parboiled dehusked red rice (Oryza sativa L.) in streptozotocin-induced diabetic rats, Stärke 68 (2016) 568-580. https://doi.org/10.1002/star.201500289.

[11]

Y.L. Low, E.S. Tai, Understanding diet-gene interactions: lessons from studying nutrigenomics and cardiovascular disease, Mutat. Res. 622 (2007) 7-13. https://doi.org/10.1016/j.mrfmmm.2007.01.015.

[12]

K. Feng, X. Zhu, T. Chen, et al., Prevention of obesity and hyperlipidemia by heptamethoxyflavone in high-fat diet-induced rats, J. Agric. Food Chem. 67 (2019) 2476-2489. https://doi.org/10.1021/acs.jafc.8b05632.

[13]

Y. Nie, F. Luo, L. Wang, et al., Anti-hyperlipidemic effect of rice bran polysaccharide and its potential mechanism in high-fat diet mice, Food Funct. 8 (2017) 4028-4041. https://doi.org/10.1039/c7fo00654c.

[14]

H. Fukui, Gut microbiota and host reaction in liver diseases, Microorganisms 3 (2015) 759-791. https://doi.org/10.3390/microorganisms3040759.

[15]

C.A. Herter, A.I. Kendall, The influence of dietary alternations on the types of intestinal flora, J. Biol. Chem. 7 (1910) 203-239. https://doi.org/10.1016/s0021-9258(18)91573-5.

[16]

M.W. Wong, C.H. Yi, T.T. Liu, et al., Impact of vegan diets on gut microbiota: an update on the clinical implications, Tzu. Chi. Med. J. 30 (2018) 200-203. https://doi.org/10.4103/tcmj.tcmj_21_18.

[17]

F. Han, Y. Wang, Y. Han, et al., Effects of whole-grain rice and wheat on composition of gut microbiota and short-chain fatty acids in rats, J. Agric. Food Chem. 66 (2018) 6326-6335. https://doi.org/10.1021/acs.jafc.8b01891.

[18]

L. Wang, Q. Lin, T. Yang, et al., Oryzanol modifies high fat diet-induced obesity, liver gene expression profile, and inflammation response in mice, J. Agric. Food Chem. 65 (2017) 8374-8385. https://doi.org/10.1021/acs.jafc.7b03230.

[19]

D. Hall, A.E. Geerts, Y. Ravussin, et al., Peroxisomal and microsomal lipid pathways associated with resistance to hepatic steatosis and reduced pro-inflammatory state, J. Biol. Chem. 285 (2010) 31011-31023. https://doi.org/10.1074/jbc.M110.127159.

[20]

P.T. Xiao, S.Y. Liu, Y.J. Kuang, et al., Network pharmacology analysis and experimental validation to explore the mechanism of sea buckthorn flavonoids on hyperlipidemia, J. Ethnopharmacol. 264 (2021) 113380.https://doi.org/10.1016/j.jep.2020.113380.

[21]

Y. Lin, N. Ren, S. Li, et al., Novel anti-obesity effect of scutellarein and potential underlying mechanism of actions, Biomed. Pharmacother. 117 (2019) 109042. https://doi.org/10.1016/j.biopha.2019.109042.

[22]

Y.P. Zhang, Y.J. Deng, K.R. Tang, et al., Berberine ameliorates high-fat diet-induced non-alcoholic fatty liver disease in rats via activation of SIRT3/AMPK/ACC pathway, Curr. Med. Sci. 39 (2019) 37-43. https://doi.org/10.1007/s11596-019-1997-3.

[23]

L. Regue, L. Minichiello, J. Avruch, et al., Liver-specific deletion of IGF2 mRNA binding protein-2/IMP2 reduces hepatic fatty acid oxidation and increases hepatic triglyceride accumulation, J. Biol. Chem. 294 (2019) 11944-11951. https://doi.org/10.1074/jbc.RA119.008778.

[24]

M. Hao, Z. Guan, Y. Gao, et al., Huang-Qi San ameliorates hyperlipidemia with obesity rats via activating brown adipocytes and converting white adipocytes into brown-like adipocytes, Phytomedicine 78 (2020) 153292.https://doi.org/10.1016/j.phymed.2020.153292.

[25]

J. Tanabe, N. Tamasawa, M. Yamashita, et al., Effects of combined PPARγ and PPARα agonist therapy on reverse cholesterol transport in the Zucker diabetic fatty rat, Diabetes Obes. Metab. 10 (2008) 772-779. https://doi.org/10.1111/j.1463-1326.2007.00810.x.

[26]

L.K.L. Øyri, I. Narverud, M.P. Bogsrud, et al., Postprandial changes in gene expression of cholesterol influx and efflux mediators after intake of SFA compared with n-6 PUFA in subjects with and without familial hypercholesterolaemia: secondary outcomes of a randomised controlled trial, J. Nutr. Sci. 8 (2019) 1-8. https://doi.org/10.1017/jns.2019.25.

[27]

P. Singh, P. Sharma, K.R. Sahakyan, et al., Differential effects of leptin on adiponectin expression with weight gain versus obesity, Int. J. Obes. (Lond).40 (2016) 266-274. https://doi.org/10.1038/ijo.2015.181.

[28]

S. Lorente-Cebrián, P. Decaunes, E. Dungner, et al., Allograft inflammatory factor 1 (AIF-1) is a new human adipokine involved in adipose inflammation in obese women, BMC Endocr. Disord. 13 (2013) 54-61. https://doi.org/10.1186/1472-6823-13-54.

[29]

M. Fukui, M. Tanaka, H. Toda, et al., The serum concentration of allograft inflammatory factor-1 is correlated with metabolic parameters in healthy subjects, Metabolism 61 (2012) 1021-1025. https://doi.org/10.1016/j.metabol.2011.12.001.

[30]

K. Tomita, B.L. Freeman, S.F. Bronk, et al., CXCL10-mediates macrophage, but not other innate immune cells-associated inflammation in murine nonalcoholic steatohepatitis, Sci. Rep. 6 (2016) 28786. https://doi.org/10.1038/srep28786.

[31]

H.S. Lee, J.H. Park, J.H. Kang, et al., Chemokine and chemokine receptor gene expression in the mesenteric adipose tissue of KKAy mice, Cytokine 46 (2009) 160-165. https://doi.org/10.1016/j.cyto.2008.12.025.

[32]

F. Yuan, H. Wang, Y. Tian, et al., Fish oil alleviated high-fat diet-induced non-alcoholic fatty liver disease via regulating hepatic lipids metabolism and metaflammation: a transcriptomic study, Lipids Health Dis. 15 (2016) 20-32.https://doi.org/10.1186/s12944-016-0190-y.

[33]

C.N. Lumeng, A.R. Saltiel, Inflammatory links between obesity and metabolic disease, J. Clin. Invest. 121 (2011) 2111-2117. https://doi.org/10.1172/JCI57132.

[34]

P.A. Dimitriu, G. Boyce, A. Samarakoon, et al., Temporal stability of the mouse gut microbiota in relation to innate and adaptive immunity, Environ. Microbiol. Rep. 5 (2013) 200-210. https://doi.org/10.1111/j.1758-2229.2012.00393.x.

[35]

A. Eljaafari, J. Pestel, B. Le Magueresse-Battistoni, et al., Adipose-tissuederived mesenchymal stem cells mediate PD-L1 overexpression in the white adipose tissue of obese individuals, resulting in T cell dysfunction, Cells 10 (2021) 2645-2657. https://doi.org/10.3390/cells10102645.

[36]

W. Li, N. Sultana, L. Yuan, et al., CD74 in apoptotic macrophages is associated with inflammation, plaque progression and clinical manifestations in human atherosclerotic lesions, Metabolites 12 (2022) 54-65. https://doi.org/10.3390/metabo12010054.

[37]

Z. Wei, P. Li, S. Huang, et al., Identification of key genes and molecular mechanisms associated with low egg production of broiler breeder hens in ad libitum, BMC Genomics 20 (2019) 408-416. https://doi.org/10.1186/s12864-019-5801-3.

[38]

X. Wang, D. Chen, Y. Li, et al., Alleviating effects of walnut green husk extract on disorders of lipid levels and gut bacteria flora in high fat diet-induced obesity rats, J. Funct. Foods 52 (2019) 576-586. https://doi.org/10.1016/j.jff.2018.11.022.

[39]

Y. Liu, Y. Gao, F. Ma, et al., The ameliorative effect of Lactobacillus plantarum Y44 oral administration on inflammation and lipid metabolism in obese mice fed with a high fat diet, Food Funct. 11 (2020) 5024-5039.https://doi.org/10.1039/d0fo00439a.

[40]

R. Zhao, Y. Ji, X. Chen, et al., Effects of a beta-type glycosidic polysaccharide from Flammulina velutipes on anti-inflammation and gut microbiota modulation in colitis mice, Food Funct. 11 (2020) 4259-4274.https://doi.org/10.1039/c9fo03017d.

[41]

X. Li, Z. Li, Y. He, et al., Regional distribution of Christensenellaceae and its associations with metabolic syndrome based on a population-level analysis, PeerJ 8 (2020) e9591. https://doi.org/10.7717/peerj.9591.

[42]

M.C. Zhou, P. Yu, Q. Sun, et al., Expression profiling analysis: uncoupling protein 2 deficiency improves hepatic glucose, lipid profiles and insulin sensitivity in high-fat diet-fed mice by modulating expression of genes in peroxisome proliferator-activated receptor signaling pathway, J. Diabetes Investig. 7 (2016) 179-189. https://doi.org/10.1111/jdi.12402.

[43]

N. Hu, C. Chen, J. Wang, et al., Atorvastatin ester regulates lipid metabolism in hyperlipidemia rats via the PPAR-signaling pathway and HMGCR expression in the liver, Int. J. Mol. Sci. 22 (2021) 11107. https://doi.org/10.3390/ijms222011107.

Food Science and Human Wellness
Pages 1422-1438
Cite this article:
Wu X, Guo T, Li B, et al. Parboiled rice supplementation alleviates high-fat diet-induced hyperlipidemia by regulating genes and gut microbiota in mice. Food Science and Human Wellness, 2024, 13(3): 1422-1438. https://doi.org/10.26599/FSHW.2022.9250120

1217

Views

293

Downloads

1

Crossref

1

Web of Science

1

Scopus

0

CSCD

Altmetrics

Received: 12 September 2022
Revised: 14 October 2022
Accepted: 29 November 2022
Published: 08 February 2024
© 2024 Beijing Academy of Food Sciences. Publishing services by Tsinghua University Press.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Return